TrademarkOpen
Search / United States / 90497833

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

D

Registered
Used for: Pharmaceutical preparations for the treatment of degenerative disorders and diseases, ocular disorders and diseases…
Show more

Class 5: Pharmaceutical preparations for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; small molecule therapies, namely, pharmaceutical preparations, for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer
Class 42: Pharmaceutical research and products development of pharmaceuticals for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; product, scientific, and pharmaceutical research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, ocular disorders and diseases, and cancer; medical and scientific research in the field of pharmaceuticals

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 2 Feb 2021
    Application filed
    New Application Entered
  2. 18 Aug 2021
    Assigned to an examining attorney
    Assigned To Examiner
  3. 23 Aug 2021
    Office action issued
    Non-Final Action Written
  4. 15 Feb 2022
    Response to office action filed
    Teas Response To Office Action Received
  5. 16 Feb 2022
    Approved for publication
    Approved For Pub - Principal Register
  6. 22 Mar 2022
    Published for opposition
    Published For Opposition
  7. 17 May 2022
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 15 Nov 2022
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 15 May 2023
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 20 Oct 2023
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  11. 10 Sep 2024
    Statement of use filed
    Teas Statement Of Use Received
  12. 12 Nov 2024
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  13. 3 Dec 2024
    Registered on the Principal Register
    Registered-Principal Register
All 38 events
2024-12-03Registered-Principal Register
2024-12-03Notice Of Registration Confirmation Emailed
2024-11-12Case Assigned To Intent To Use Paralegal
2024-11-12Statement Of Use Processing Complete
2024-11-12Allowed Principal Register - Sou Accepted
2024-11-12Notice Of Acceptance Of Statement Of Use E-Mailed
2024-09-10Teas Statement Of Use Received
2024-09-10Use Amendment Filed
2024-04-30Notice Of Approval Of Extension Request E-Mailed
2024-04-29Sou Teas Extension Received
2024-04-29Sou Extension 4 Filed
2024-04-29Sou Extension 4 Granted
2023-10-24Notice Of Approval Of Extension Request E-Mailed
2023-10-20Sou Teas Extension Received
2023-10-20Sou Extension 3 Filed
2023-10-20Sou Extension 3 Granted
2023-05-17Notice Of Approval Of Extension Request E-Mailed
2023-05-15Sou Teas Extension Received
2023-05-15Sou Extension 2 Filed
2023-05-15Sou Extension 2 Granted
2022-11-17Notice Of Approval Of Extension Request E-Mailed
2022-11-15Sou Teas Extension Received
2022-11-15Sou Extension 1 Filed
2022-11-15Sou Extension 1 Granted
2022-05-17Noa Mailed - Sou Required From Applicant
2022-03-22Published For Opposition
2022-03-22Official Gazette Publication Confirmation E-Mailed
2022-03-02Notification Of Notice Of Publication E-Mailed
2022-02-16Teas/Email Correspondence Entered
2022-02-16Approved For Pub - Principal Register
2022-02-15Teas Response To Office Action Received
2022-02-15Correspondence Received In Law Office
2021-08-23Non-Final Action Written
2021-08-23Non-Final Action E-Mailed
2021-08-23Notification Of Non-Final Action E-Mailed
2021-08-18Assigned To Examiner
2021-05-01New Application Office Supplied Data Entered
2021-02-02New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; small molecule therapies, namely, pharmaceutical preparations, for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer

First use anywhere 5 Aug 2024 · First use in commerce 5 Aug 2024

Class 42 Technology & SaaS

Pharmaceutical research and products development of pharmaceuticals for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; product, scientific, and pharmaceutical research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, ocular disorders and diseases, and cancer; medical and scientific research in the field of pharmaceuticals

First use anywhere 4 Mar 2021 · First use in commerce 4 Mar 2021

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 3 Dec 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.